中国循证医学杂志

中国循证医学杂志

使用常规收集卫生数据开展观察性研究的报告规范-RECORD 规范

查看全文

常规收集卫生数据是指基于管理和临床目的且事先没有特定研究目标而收集的数据,已被越来越多地用于研究。此类数据发展迅速,可及性好,但相关注意事项并未在现有的报告规范中被提及,如加强观察性流行病学研究报告的声明(strengthening the reporting of observational studies in epidemiology statement,STROBE)。使用常规收集卫生数据开展观察性研究的报告规范(the report of studies conducted using observational routinely collected data,RECORD)可填补该空缺。RECORD 规范是 STROBE 规范扩展版,其可用来提出针对使用常规收集卫生数据开展观察性研究有关报告的条件要求。RECORD 清单扩展了包括题目、摘要、前言、方法、结果、讨论和其他内容等需要在此类研究报告中包含的 13 个条目内容。该规范包括了清单、详尽的解释性信息以提高清单的使用。该规范还给出每条 RECORD 清单条目良好的报告实例。本文及其官网和留言板(http://www.record-statement.org)可提高 REDORD 规范的应用和理解。通过应用 RECORD,作者、期刊编辑和同行评议者可促进研究报告的质量。

关键词: RECORD 规范; 指南

引用本文: 聂晓璐, 彭晓霞, 译. 使用常规收集卫生数据开展观察性研究的报告规范-RECORD 规范. 中国循证医学杂志, 2017, 17(4): 475-487. doi: 10.7507/1672-2531.201702009 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Spasoff RA. Epidemiologic Methods for Health Policy. New York: Oxford University Press, 1999.
2. Morrato EH, Elias M, Gericke CA. Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA. J Public Health, 2007, 29(4): 463-471.
3. De Coster C, Quan H, Finlayson A,et al. Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv Res, 2006, 6: 77.
4. Hemkens LG, Benchimol EI, Langan SM,et al. Reporting of studies using routinely collected health data: systematic literature analysis (oral abstract presentation). Edinburgh, UK: Reward/equator conference, 2015.
5. Benchimol EI, Manuel DG, To T,et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol, 2011, 64(8): 821-829.
6. Herrett E, Thomas SL, Schoonen WM,et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol, 2010, 69(1): 4-14.
7. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edition. Philadelphia: Lippincott Williams & Wilkins, 2008.
8. Plint AC, Moher D, Morrison A,et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust, 2006, 185(5): 263-267.
9. Enhancing the quality and transparency of health research (EQUATOR) network library 2015. Available at: www.equator-network.org/library/.
10. Vandenbroucke JP, von Elm E, Altman DG,et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLOS Med, 2007, 4(10): e297.
11. von Elm E, Altman DG, Egger M,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLOS Med, 2007, 4(10): e296.
12. Sorensen AA, Wojahn RD, Manske MC,et al. Using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement to assess reporting of observational trials in hand surgery. J Hand Surg Am, 2013, 38(8): 1584-1589.
13. Cobo E, Cortes J, Ribera JM,et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ, 2011, 343: d6783.
14. Benchimol EI, Langan S, Guttmann A. Call to RECORD: the need for complete reporting of research using routinely collected health data. J Clin Epidemiol, 2013, 66(7): 703-705.
15. Langan SM, Benchimol EI, Guttmann A,et al. Setting the RECORD straight: developing a guideline for the REporting of studies Conducted using Observational Routinely collected Data. Clin Epidemiol, 2013, 5: 29-31.
16. Nicholls SG, Quach P, von Elm E,et al. The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement: Methods for Arriving at Consensus and Developing Reporting Guidelines. PLOS One, 2015, 10(5): e0125620.
17. Moher D, Schulz KF, Simera I,et al. Guidance for developers of health research reporting guidelines. PLOS Med, 2010, 7(2): e1000217.
18. Glasziou P, Altman DG, Bossuyt P,et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet, 2014, 383(9913): 267-276.
19. Blotiere PO, Weill A, Ricordeau P,et al. Perforations and haemorrhages after colonoscopy in 2010: a study based on comprehensive French health insurance data (SNIIRAM). Clin Res Hepatol Gastroenterol, 2014, 38(1): 112-117.
20. Siregar S, Pouw ME, Moons KG,et al. The Dutch hospital standardised mortality ratio (HSMR) method and cardiac surgery: benchmarking in a national cohort using hospital administration data versus a clinical database. Heart, 2014, 100(9): 702-710.
21. Price SD, Holman CD, Sanfilippo FM,et al. Use of case-time-control design in pharmacovigilance applications: exploration with high-risk medications and unplanned hospital admissions in the Western Australian elderly. Pharmacoepidemiol Drug Saf, 2013, 22(11): 1159-1170.
22. Gross CP, Andersen MS, Krumholz HM,et al. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA, 2006, 296(23): 2815-2822.
23. Vandenbroucke JP. Observational research, randomised trials, and two views of medical science. PLOS Med, 2008, 5(3): e67.
24. Smith GD, Ebrahim S. Data dredging, bias, or confounding. BMJ, 2002, 325(7378): 1437-1438.
25. Prokosch HU, Ganslandt T. Perspectives for medical informatics. Reusing the electronic medical record for clinical research. Methods Inf Med, 2009, 48(1): 38-44.
26. Benchimol EI, Manuel DG, Guttmann A,et al. Changing age demographics of inflammatory bowel disease in ontario, canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis, 2014, 20(10): 1761-1769.
27. Ducharme R, Benchimol EI, Deeks SL,et al. Validation of diagnostic codes for intussusception and quantification of childhood intussusception incidence in ontario, Canada: a population-based study. J Pediatr, 2013, 163(4): 1073-1079.
28. Herrett E, Shah AD, Boggon R,et al. Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ, 2013, 346: f2350.
29. van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE,et al. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer, 2010, 46(2): 395-404.
30. Fosbol EL, Granger CB, Peterson ED,et al. Prehospital system delay in STsegment elevation myocardial infarction care: a novel linkage of emergency medicine services and in hospital registry data. Am Heart J, 2013, 165(3): 363-370.
31. Manuel DG, Rosella LC, Stukel TA. Importance of accurately identifying disease in studies using electronic health records. BMJ, 2010, 341: c4226.
32. Narcolepsy in association with pandemic influenza vaccination (a multi-country European epidemiological investigation). Stockholm: ECDC, 2012.
33. Lewis JD, Schinnar R, Bilker WB,et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf, 2007, 16(4): 393-401.
34. Sorensen HT, Sabroe S, Olsen J. A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol, 1996, 25(2): 435-442.
35. Baron JA, Lu-Yao G, Barrett J,et al. Internal validation of Medicare claims data. Epidemiology, 1994, 5(5): 541-544.
36. Marston L, Carpenter JR, Walters KR,et al. Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study. BMJ open, 2014, 4(4): e004958.
37. Hardelid P, Dattani N, Gilbert R. Estimating the prevalence of chronic conditions in children who die in England, Scotland and Wales: a data linkage cohort study. BMJ Open, 2014, 4(8): e005331.
38. Murray J, Bottle A, Sharland M,et al. Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLOS One, 2014, 9(2): e89186.
39. Berry JG, Hall M, Hall DE,et al. Inpatient growth and resource use in 28 children's hospitals: a longitudinal, multi-institutional study. JAMA pediatrics, 2013, 167(2): 170-177.
40. Shahian DM, Wolf RE, Iezzoni LI,et al. Variability in the measurement of hospital-wide mortality rates. N Engl J Med, 2010, 363(26): 2530-2539.
41. Springate DA, Kontopantelis E, Ashcroft DM,et al. ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronicmedical records. PLOS One, 2014, 9(6): e99825.
42. Dommett RM, Redaniel MT, Stevens MC,et al. Features of childhood cancer in primary care: a population-based nested case-control study. Br J Cancer, 2012, 106(5): 982-987.
43. Tsang C, Bottle A, Majeed A,et al. Adverse events recorded in English primary care: observational study using the General Practice Research Database. Br J Gen Pract, 2013, 63(613): e534-42.
44. Harron K, Goldstein H, Wade A,et al. Linkage, evaluation and analysis of national electronic healthcare data: application to providing enhanced blood-stream infection surveillance in paediatric intensive care. PLOS One, 2013, 8(12): e85278.
45. Adams MM, Wilson HG, Casto DL,et al. Constructing reproductive histories by linking vital records. Am J Epidemiol, 1997, 145(4): 339-348.
46. Ford JB, Roberts CL, Taylor LK. Characteristics of unmatched maternal and baby records in linked birth records and hospital discharge data. Paediatr Perinat Epidemiol, 2006, 20(4): 329-337.
47. Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc, 2013, 20(1): 144-151.
48. Sandall J, Murrells T, Dodwell M,et al. The efficient use of the maternity workforce and the implications for safety and quality in maternity care: a population-based, cross-sectional study. Health Serv Deliv Res, 2014, 2: 38. Available at: .
49. Welch C, Petersen I, Walters K,et al. Two-stage method to remove population- and individual-level outliers from longitudinal data in a primary care database. Pharmacoepidemiol Drug Saf, 2012, 21(7): 725-732.
50. Van den Broeck J, Cunningham SA, Eeckels R,et al. Data cleaning: detecting, diagnosing, and editing data abnormalities. PLOS Med, 2005, 2(10): e267.
51. Bohensky MA, Jolley D, Sundararajan V,et al. Data linkage: a powerful research tool with potential problems. BMC Health Serv Res, 2010, 10: 346.
52. Harron K, Wade A, Muller-Pebody B,et al. Opening the black box of record linkage. J Epidemiol Community Health, 2012, 66(12): 1198.
53. Lariscy JT. Differential record linkage by Hispanic ethnicity and age in linked mortality studies: implications for the epidemiologic paradox. J Aging Health, 2011, 23(8): 1263-1284.
54. Dinan MA, Curtis LH, Carpenter WR,et al. Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology, 2013, 267(3): 807-817.
55. Horsfall L, Walters K, Petersen I. Identifying periods of acceptable computer usage in primary care research databases. Pharmacoepidemiol Drug Saf, 2013, 22(1): 64-69.
56. Gerber DE, Laccetti AL, Xuan L,et al. Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst, 2014, 106(11): dju302.
57. Carrara G, Scire CA, Zambon A,et al. A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. Results from the record linkage On Rheumatic Diseases study of the Italian Society for Rheumatology. BMJ Open, 2015, 5(1): e006029.
58. Rait G, Walters K, Griffin M,et al. Recent trends in the incidence of recorded depression in primary care. Br J Psychiatry, 2009, 195(6): 520-524.
59. Wijlaars LP, Nazareth I, Petersen I. Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN). PLOS One, 2012, 7(3): e33181.
60. Jeon CY, Pandol SJ, Wu B,et al. The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis. PLOS One, 2015, 10(4): e0121783.
61. Pruitt Z, Pracht E. Upcoding emergency admissions for non-life-threatening injuries to children. Am J Manag Care, 2013, 19(11): 917-924.
62. McLintock K, Russell AM, Alderson SL,et al. The effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysis. BMJ Open, 2014, 4(8): e005178.
63. Brunt CS. CPT fee differentials and visit upcoding under Medicare Part B. Health Economics, 2011, 20(7): 831-841.
64. Walters K, Rait G, Griffin M,et al. Recent trends in the incidence of anxiety diagnoses and symptoms in primary care. PLOS One, 2012, 7(8): e41670.
65. Nilson F, Bonander C, Andersson R. The effect of the transition from the ninth to the tenth revision of the International Classification of Diseases on external cause registration of injury morbidity in Sweden. Inj Prev, 2015, 21(3): 189-194.
66. Jagai JS, Smith GS, Schmid JE,et al. Trends in gastroenteritis-associated mortality in the United States, 1985 inverted question mark 2005: variations by ICD-9 and ICD-10 codes. BMC Gastroenterol, 2014, 14(1): 211.
67. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance Guide on Methodological Standards in Pharmacoepidemiology, 4.2.2.5. London: European Medicines Agency, 2015. Available at: www.encepp.eu/standards_ and_guidances/methodologicalGuide4_2_2_5.shtml.
68. Toh S, Garcia RLA, Hernan MA. Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf, 2011, 20(8): 849-857.
69. Stukel TA, Fisher ES, Wennberg DE,et al. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA, 2007, 297(3): 278-285.
70. Austin PC. An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res, 2011, 46(3): 399-424.
71. Sterne JA, White IR, Carlin JB,et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ, 2009, 338: b2393.
72. Freemantle N, Marston L, Walters K,et al. Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research. BMJ, 2013, 347: f6409.
73. Marston L, Carpenter JR, Walters KR,et al. Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf, 2010, 19(6): 618-626.
74. Benchimol EI, To T, Griffiths AM,et al. Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. J Pediatr, 2011, 158(6): 960-967.
75. Nassar N, Dixon G, Bourke J,et al. Autism spectrum disorders in young children: effect of changes in diagnostic practices. Int J Epidemiol, 2009, 38(5): 1245-1254.
76. Tan GH, Bhoo-Pathy N, Taib NA,et al. The Will Rogers phenomenon in the staging of breast cancer-does it matter? Cancer Epidemiol, 2015, 39(1): 115-117.
77. Taljaard M, Tuna M, Bennett C,et al. Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol. BMJ Open, 2014, 4(10): e006701.
78. Guttmann A, Schull MJ, Vermeulen MJ,et al. Association between waiting times and short term mortality and hospital admission after departure from emergency department: population based cohort study from Ontario, Canada. BMJ, 2011, 342: d2983.
79. Nicol A, Caruso J, Archambault E. Open Data Access Policies and Strategies in the European Research Area and Beyond. Montreal: Science-Metrix Inc, 2013.
80. Fuller T, Pearson M, Peters J,et al. What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews. PLOS One, 2015, 10(4): e0121585.
81. Turner L, Shamseer L, Altman DG,et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev, 2012, 11: MR000030.
82. Armstrong R, Waters E, Moore L,et al. Improving the reporting of public health intervention research: advancing TREND and CONSORT. J Public Health (Oxf), 2008, 30(1): 103-109.
83. Moher D, Cook DJ, Eastwood S,et al. Improving the quality of reports of metaanalyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet, 1999, 354(9193): 1896-1900.
84. Prady SL, Richmond SJ, Morton VM,et al. A systematic evaluation of the impact of STRICTA and CONSORT recommendations on quality of reporting for acupuncture trials. PLOS One, 2008, 3(2): e1577.